Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Companion Animal Diagnostic Market analysis

The UK Companion Animal Diagnostic Market was valued at $117.3 Million in 2026 and projected to reach to $167.3 Million by 2031, representing a compound annual growth rate of CAGR 7.4%. The UK companion animal diagnostic market is positioned for steady growth through 2031, driven by rising pet ownership, elevated consumer spending on pet wellness, and the expansion of veterinary diagnostic capabilities across the country.

UK Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Companion Animal Diagnostic Market Trends and Insights

  • The UK market benefits from high pet ownership rates, advanced veterinary infrastructure, and increasing consumer spending on pet healthcare.
  • In the UK, diagnostic services including imaging, laboratory testing, and point-of-care diagnostics are becoming essential components of routine veterinary care, driven by pet owners' willingness to invest in preventive and early-detection health solutions. The UK companion animal diagnostic market is experiencing steady expansion as veterinary practices adopt advanced diagnostic technologies and digital health solutions.
  • UK veterinarians are increasingly integrating in-house diagnostic capabilities to improve clinical outcomes and reduce turnaround times for pet owners.
  • Between 2026 and 2031, the UK market will be shaped by rising awareness of zoonotic diseases, aging pet populations requiring more frequent testing, and the growing adoption of telemedicine-integrated diagnostics in UK veterinary clinics..

Key Market Statistics

  • CAGR (2026-2031) CAGR 7.4%
  • Market Size, 2026 ~USD 117.3 Million
  • Forecast, 2031 ~USD 167.3 Million
  • Country UK

UK Companion Animal Diagnostic Market Overview

Market Size & Growth :

The UK companion animal diagnostic market is valued at $117.3 million in 2026 and is projected to reach $167.3 million by 2031, with a CAGR of 7.4%, outpacing many European counterparts.

High Pet Ownership Rates :

The UK has one of the highest pet ownership rates in Europe, with approximately 59% of households owning pets, driving sustained demand for veterinary diagnostic services and preventive care solutions.

Advanced Veterinary Infrastructure :

The UK boasts a well-established network of modern veterinary clinics and animal hospitals equipped with state-of-the-art diagnostic technologies, supporting rapid adoption of innovative testing solutions.

Increasing Pet Healthcare Spending :

UK pet owners are increasingly willing to invest in comprehensive diagnostic services, with pet healthcare expenditure growing as awareness of early disease detection and preventive medicine rises.

UK Companion Animal Diagnostic Market Dynamics

  • The market benefits from strong regulatory frameworks, high-quality veterinary education, and increasing adoption of advanced imaging and laboratory technologies in clinical practice. Key growth drivers include the shift towards preventive healthcare, integration of digital diagnostic tools, and growing demand for rapid point-of-care testing in veterinary clinics.
  • The UK's mature pet care market and affluent pet-owning demographic create favorable conditions for premium diagnostic services, positioning the market for sustained expansion over the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK companion animal diagnostic market is valued at $117.3 million in 2026 and will reach $167.3 million by 2031 at a 7.4% CAGR.
    • UK veterinary practices are increasingly adopting advanced diagnostic technologies including imaging, laboratory testing, and point-of-care solutions.
    • High pet ownership and strong consumer spending on pet healthcare are primary growth drivers in the UK market.
    • The UK market is being shaped by aging pet populations, zoonotic disease awareness, and telemedicine-integrated diagnostic adoption.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    UK Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    Target Audience

    • Veterinary Diagnostic Companies : UK-based and international diagnostic manufacturers need market-specific data to assess market potential, identify growth opportunities, and develop targeted go-to-market strategies for the British veterinary sector.
    • Veterinary Clinic Operators : Independent and chain veterinary practices require insights into diagnostic market trends and consumer preferences to optimize service offerings, invest in equipment, and enhance competitive positioning.
    • Private Equity & Investors : Investment firms evaluating opportunities in the UK pet healthcare sector need comprehensive market analysis to assess valuations, growth potential, and investment returns in companion animal diagnostics.
    • Veterinary Distributors & Suppliers : Distributors and suppliers of diagnostic equipment and reagents need UK market intelligence to forecast demand, optimize inventory, and identify partnership opportunities with veterinary providers.
    • Healthcare Consultants & Advisors : Management consultants and business advisors serving the UK veterinary industry require detailed market data to support client strategy development, market entry planning, and competitive analysis.

    Key Companies in the UK Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise market valuation and forecasts tailored exclusively to the UK market, enabling accurate budgeting and investment decisions for veterinary diagnostic businesses operating in Britain.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to the UK veterinary diagnostic sector, including key players, market share distribution, and strategic positioning within the British market.
    • Growth Opportunity Identification : Identify high-potential segments and geographic hotspots within the UK where companion animal diagnostic demand is accelerating, supporting targeted expansion and resource allocation strategies.
    • Regulatory & Market Insights : Gain insights into UK-specific regulatory requirements, veterinary standards, and market dynamics that influence diagnostic adoption and reimbursement patterns in British veterinary practices.
    • Strategic Planning & Forecasting : Leverage detailed UK market forecasts through 2031 to inform long-term strategic planning, product development, and market entry strategies for the British companion animal diagnostic sector.

    Frequently asked questions

    What is the current size of the UK companion animal diagnostic market?

    The UK companion animal diagnostic market is valued at $117.3 million in 2026 and is expected to grow to $167.3 million by 2031.

    What is the growth rate of the UK companion animal diagnostic market?

    The UK companion animal diagnostic market is growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2031.

    What diagnostic services are driving growth in the UK market?

    In the UK, imaging, laboratory testing, point-of-care diagnostics, and telemedicine-integrated solutions are the primary diagnostic services driving market expansion.

    Why is the UK companion animal diagnostic market growing?

    The UK market is growing due to high pet ownership rates, increased consumer spending on pet healthcare, aging pet populations, and adoption of advanced veterinary technologies.

    What factors will influence the UK market between 2026 and 2031?

    Key factors influencing the UK market include rising zoonotic disease awareness, aging pet demographics, telemedicine integration, and veterinary practice modernization.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status